Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 04/03/2020

Closing price: 78.21

Support price level:	$72.27
Resistance price level:	N/A
Relative strength index (14-day RSI)	61.5
Beta	0.16

GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
GILD is one of this month's top performers with a return of -2.5 percent, beating 90 percent of stocks in the S&P-100.
Up 7.4 percent, GILD is one of this week's biggest gainers.
The price of this low-beta stock is expected to increase by 0.16% for every 1% increase in the S&P-500.
Volatility is forecast to fall over the next month.
Price broke above prior resistance level - a short-term bullish signal.

Low	High	Price as % of Range
$61.62	$80.22	90.4%

200 day	50 day	20 day	10 day
$66.70	$70.91	$73.74	$74.13

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
28.2%	39.3%	56.8%	32.9%

There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than: